{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:31:41Z","timestamp":1772602301573,"version":"3.50.1"},"reference-count":29,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3892\/etm.2014.2152","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T07:37:13Z","timestamp":1418974633000},"page":"658-666","source":"Crossref","is-referenced-by-count":46,"title":["Multimodal therapy for category III chronic prostatitis\/chronic pelvic pain syndrome in UPOINTS phenotyped patients"],"prefix":"10.3892","volume":"9","author":[{"given":"VITTORIO","family":"MAGRI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EMANUELA","family":"MARRAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANTONELLA","family":"RESTELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FLORIAN M.E.","family":"WAGENLEHNER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIANPAOLO","family":"PERLETTI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,12,19]]},"reference":[{"key":"key20180108125649_b1-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.med.57.011205.135654","article-title":"Prostatitis\/chronic pelvic pain syndrome","volume":"57","author":"Habermacher","year":"2006","journal-title":"Annu Rev Med"},{"key":"key20180108125649_b2-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1464-410X.2010.09701.x","article-title":"Phenotypic approach to the management of the chronic prostatitis\/chronic pelvic pain syndrome","volume":"106","author":"Nickel","year":"2010","journal-title":"BJU Int"},{"key":"key20180108125649_b3-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/pcan.2008.42","article-title":"Clinical phenotyping in chronic prostatitis\/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes","volume":"12","author":"Shoskes","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key20180108125649_b4-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00345-013-1062-y","article-title":"Management of chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS): the studies, the evidence and the impact","volume":"31","author":"Nickel","year":"2013","journal-title":"World J Urol"},{"key":"key20180108125649_b5-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.ju.0000131592.98562.16","article-title":"Failure of a monotherapy strategy for difficult chronic prostatitis\/chronic pelvic pain syndrome","volume":"172","author":"Nickel","year":"2004","journal-title":"J Urol"},{"key":"key20180108125649_b6-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/01.ju.0000055549.95490.3c","article-title":"Long-term results of multimodal therapy for chronic prostatitis\/chronic pelvic pain syndrome","volume":"169","author":"Shoskes","year":"2003","journal-title":"J Urol"},{"key":"key20180108125649_b7-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.urology.2010.01.021","article-title":"Phenotypically directed multimodal therapy for chronic prostatitis\/chronic pelvic pain syndrome: a prospective study using UPOINT","volume":"75","author":"Shoskes","year":"2010","journal-title":"Urology"},{"key":"key20180108125649_b8-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.juro.2010.08.025","article-title":"Use of the UPOINT chronic prostatitis\/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations","volume":"184","author":"Magri","year":"2010","journal-title":"J Urol"},{"key":"key20180108125649_b9-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.juro.2012.07.036","article-title":"Clustering of UPOINT domains and subdomains in men with chronic prostatitis\/chronic pelvic pain syndrome and contribution to symptom severity","volume":"188","author":"Samplaski","year":"2012","journal-title":"J Urol"},{"key":"key20180108125649_b10-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"e52044","DOI":"10.1371\/journal.pone.0052044","article-title":"Clinical utility of the UPOINT phenotype system in Chinese males with chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS): a prospective study","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"key20180108125649_b11-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00345-013-1075-6","article-title":"Classification and treatment of men with chronic prostatitis\/chronic pelvic pain syndrome using the UPOINT system","volume":"31","author":"Shoskes","year":"2013","journal-title":"World J Urol"},{"key":"key20180108125649_b12-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.juro.2012.08.083","article-title":"Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs \u2018UPOINT\u2019 to yes","volume":"189","author":"Davis","year":"2013","journal-title":"J Urol"},{"key":"key20180108125649_b13-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.eururo.2004.12.025","article-title":"The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index","volume":"47","author":"Giubilei","year":"2005","journal-title":"Eur Urol"},{"key":"key20180108125649_b14-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11136-005-1317-1","article-title":"Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)","volume":"15","author":"Propert","year":"2006","journal-title":"Qual Life Res"},{"key":"key20180108125649_b15-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijir.3900857","article-title":"The International Index of Erectile Function (IIEF): a state-of-the-science review","volume":"14","author":"Rosen","year":"2002","journal-title":"Int J Impot Res"},{"key":"key20180108125649_b16-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/aja.2011.36","article-title":"Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction","volume":"13","author":"Magri","year":"2011","journal-title":"Asian J Androl"},{"key":"key20180108125649_b17-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1590\/S1677-5538.IBJU.2013.02.10","article-title":"Effects of Serenoa repens, selenium and lycopene (Profluss\u00ae) on chronic inflammation associated with benign prostatic hyperplasia: results of \u2018FLOG\u2019 (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study","volume":"39","author":"Morgia","year":"2013","journal-title":"Int Braz J Urol"},{"key":"key20180108125649_b18-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000302716","article-title":"Treatment of chronic prostatitis\/chronic pelvic pain syndrome category IIIa with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study","volume":"84","author":"Morgia","year":"2010","journal-title":"Urol Int"},{"key":"key20180108125649_b19-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2288-5-35","article-title":"Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data","volume":"5","author":"Vickers","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"key20180108125649_b20-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"key":"key20180108125649_b21-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.eururo.2012.10.042","article-title":"National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis\/chronic pelvic pain syndrome","volume":"63","author":"Wagenlehner","year":"2013","journal-title":"Eur Urol"},{"key":"key20180108125649_b22-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1517\/14656566.8.11.1667","article-title":"Therapy for prostatitis, with emphasis on bacterial prostatitis","volume":"8","author":"Wagenlehner","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"key20180108125649_b23-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00345-014-1247-z","article-title":"Immunostimulation in chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS): a one-year prospective, double-blind, placebo-controlled study","volume":"32","author":"Wagenlehner","year":"2014","journal-title":"World J Urol"},{"key":"key20180108125649_b24-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00345-013-1076-5","article-title":"Sexual dysfunction in chronic prostatitis\/chronic pelvic pain syndrome","volume":"31","author":"Tran","year":"2013","journal-title":"World J Urol"},{"key":"key20180108125649_b25-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-5347(05)64572-7","article-title":"Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study","volume":"168","author":"Schaeffer","year":"2002","journal-title":"J Urol"},{"key":"key20180108125649_b26-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.ju.0000082252.49374.e9","article-title":"Leukocytes and bacteria in men with chronic prostatitis\/chronic pelvic pain syndrome compared to asymptomatic controls","volume":"170","author":"Nickel","year":"2003","journal-title":"J Urol"},{"key":"key20180108125649_b27-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4111\/kju.2014.55.4.276","article-title":"Clinical significance of national institutes of health classification in patients with chronic prostatitis\/chronic pelvic pain syndrome","volume":"55","author":"Sung","year":"2014","journal-title":"Korean J Urol"},{"key":"key20180108125649_b28-etm-09-03-0658","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: Mechanisms of action and their relevance for clinical applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol Ther"},{"key":"key20180108125649_b29-etm-09-03-0658","first-page":"1035","article-title":"Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile","volume":"4","author":"Perletti","year":"2011","journal-title":"Mol Med Rep"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2014.2152\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T17:45:22Z","timestamp":1515433522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2014.2152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,19]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,12,19]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.3892\/etm.2014.2152"],"URL":"https:\/\/doi.org\/10.3892\/etm.2014.2152","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725350563.793536463","asserted-by":"object"}]},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,19]]}}}